Immunoglobulin-G-containing fraction

Details Immunoglobulin-G-containing fraction Immunoglobulin-G-containing fraction

1990-08-20

1992-06-16

Schain, Howard E.

Drug, bio-affecting and body treating compositions

Lymphokine

5303905, A61K 39395

Patent

active

051223732

ABSTRACT:
An immunoglobulin-G-containing fraction from human or animal plasma comprising monomeric IgG molecules as well as at least 70% gammaglobulins, destined for intravenous application.
The fraction has a low anticomplementary activity and is substantially free of vasoactive and leucopenically active as well as bronchospastic substances.

REFERENCES:
patent: 4276283 (1981-06-01), Eibl et al.
patent: 4296027 (1981-10-01), Condie
patent: 4384993 (1983-05-01), Sato et al.
patent: 4476109 (1984-10-01), Kimura et al.
patent: 4482483 (1984-11-01), Curry et al.
patent: 4499073 (1985-02-01), Tenold
Intravenous Immunoglobulin: Prevention and Treatment of Disease; NIH Consensus Development Conference; May 21,23, 1990.
Immune Globulin (Human), Intravenous; IVEEGAM; Issues May 1988; Immuno (Canada) Ltd., Windsor, Ontario.

Affiliated with

Also associated with

Rating

Immunoglobulin-G-containing fraction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunoglobulin-G-containing fraction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoglobulin-G-containing fraction will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1752679